| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5691194 | Urology | 2017 | 5 Pages |
Abstract
The rapid uptake of 68Ga prostate-specific membrane antigen HBED-CC positron emission tomography (PSMA PET) imaging for prostate cancer staging has led to concerns regarding its specificity, with uptake in both malignant and nonmalignant tissues. We describe 3 separate malignancies identified on PSMA PET imaging. The misnomer “prostate-specific membrane antigen” is demonstrated by this case and highlights the importance of continued investigation of the potential role of PSMA PET in other malignancies.
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
Andre Joshi, Cheryl Nicholson, Handoo Rhee, Sonja Gustafson, Kenneth Miles, Ian Vela,